Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Top Cited Papers
Open Access
- 13 May 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 185 (1), 1-21
- https://doi.org/10.1111/cei.12781
Abstract
Summary: CD26/DPP4 (dipeptidyl peptidase 4/DP4/DPPIV) is a surface T cell activation antigen and has been shown to have DPP4 enzymatic activity, cleaving-off amino-terminal dipeptides with either L-proline or L-alanine at the penultimate position. It plays a major role in glucose metabolism by N-terminal truncation and inactivation of the incretins glucagon-like peptide-1 (GLP) and gastric inhibitory protein (GIP). In 2006, DPP4 inhibitors have been introduced to clinics and have been demonstrated to efficiently enhance the endogenous insulin secretion via prolongation of the half-life of GLP-1 and GIP in patients. However, a large number of studies demonstrate clearly that CD26/DPP4 also plays an integral role in the immune system, particularly in T cell activation. Therefore, inhibition of DPP4 might represent a double-edged sword. Apart from the metabolic benefit, the associated immunological effects of long term DPP4 inhibition on regulatory processes such as T cell homeostasis, maturation and activation are not understood fully at this stage. The current data point to an important role for CD26/DPP4 in maintaining lymphocyte composition and function, T cell activation and co-stimulation, memory T cell generation and thymic emigration patterns during immune-senescence. In rodents, critical immune changes occur at baseline levels as well as after in-vitro and in-vivo challenge. In patients receiving DPP4 inhibitors, evidence of immunological side effects also became apparent. The scope of this review is to recapitulate the role of CD26/DPP4 in the immune system regarding its pharmacological inhibition and T cell-dependent immune regulation.Keywords
This publication has 142 references indexed in Scilit:
- The dimeric transmembrane domain of prolyl dipeptidase DPP‐IV contributes to its quaternary structure and enzymatic activitiesProtein Science, 2010
- Transferred T cells preferentially adhere in the BALT of CD26-deficient recipient lungs during asthmaImmunobiology, 2010
- Blockade of CD26-mediated T cell costimulation with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cellsBiochemical and Biophysical Research Communications, 2009
- On the role of CD26 in CD4 memory T cellsImmunobiology, 2007
- Thymic output in aged miceProceedings of the National Academy of Sciences of the United States of America, 2006
- In Vivo Modulation of the Acidic N-Glycans from Rat Liver Dipeptidyl Peptidase IV by N-Propanoyl-d-mannosamineBiochemical and Biophysical Research Communications, 1999
- Regional Expression of Epithelial Dipeptidyl Peptidase IV in the Human IntestinesBiochemical and Biophysical Research Communications, 1994
- Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) geneImmunogenetics, 1994
- Extracellular matrix proteins in intrathymic T-cell migration and differentiation?Immunology Today, 1993
- Quantitative immunogold localization of dipeptidyl peptidase IV(DPP IV) in rat liver cells.Cell Structure and Function, 1990